Loading...
Vitamin K antagonists in children with heart disease: height and VKORC1 genotype are the main determinants of the warfarin dose requirement
Managing vitamin K antagonist (VKA) therapy is challenging in children because of a narrow therapeutic range and wide inter- and intra-individual variability in dose response. Only a few small studies have investigated the effect of nongenetic and genetic factors on the dose response to VKAs in chil...
Na minha lista:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society of Hematology
2012
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3384479/ https://ncbi.nlm.nih.gov/pubmed/22130800 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2011-07-365502 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|